Last reviewed · How we verify
Treatment of Aggressive Central Giant Cell Granuloma
The main objective of this randomised clinical trial is to is to compare the frequency of recurrence between patients who received nasal spray calcitonin after curettage of Central Giant Cell Granuloma and without it.
Details
| Lead sponsor | Shiraz University of Medical Sciences |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | 2007-09 |
| Completion | 2015-04 |
Conditions
- Central Giant Cell Granuloma
Interventions
- nasal spray calcitonin
- Placebo
Primary outcomes
- Relief sign &symptom and clinical features — 5 years
Countries
Iran